CAN Center for Automation in Nanobiotech
Key development areas: Biosensor, nanobioelectronics and nanorobotics for in vivo nanomedicine application in diabetes, cancer, cardiology, and brain aneurysm.
CAN Center for Automation in Nanobiotech is a biotechnology company, focused on nanotechnologies for innovative integrated system implementation. The equipment prototyping at CAN should enable new treatments through in vivo diagnosis, drug delivery and surgery. Our business project is to provide new effective medical devices and therapeutic products for the development of commercial nanobiotechnology.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.